Join to View Full Profile
4510 Executive DrSan Diego, CA 92121
Phone+1 858-657-8540
Fax+1 858-657-8557
Dr. Rafii is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 2003 - 2006- Johns Hopkins UniversityInternship, Internal Medicine, 2002 - 2003
The Warren Alpert Medical School of Brown UniversityClass of 2002
Certifications & Licensure
CA State Medical License 2006 - 2026
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- Down Syndrome Biomarker Initiative (DSBI) Start of enrollment: 2013 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Differences in cholinergic terminal density in adults with Down syndrome compared to neurotypical controls measured by [F]-fluoroethoxybenzovesamicol positron emission...Jason K Russell, Alexander C Conley, Brian D Boyd, J Patrick Begnoche, Rachel Schlossberg
Neurobiology of Aging. 2025-04-01 - Reflecting on progress, envisioning the future for research in Down syndrome.Jonathan D Santoro, Michael S Rafii
Lancet. 2025-03-20 - Clinical and neuropathological analysis of Down syndrome over 7 decades of life.Sonal Sukreet, Vanessa S Goodwill, Jennifer Ngolab, Ha Y Kim, Solana Leisher
Journal of Neuropathology and Experimental Neurology. 2025-02-01
Journal Articles
- Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer DiseaseReisa Sperling, Michael S Rafii, Gary Romano, JAMA Neurology
Press Mentions
Alzheimer's Meds Are Here. But for the down Syndrome Community, It's Still the 1980sMarch 1st, 2023- Top Dementia Scientists Present Key Findings, InitiativesNovember 28th, 2022
- It’s Not a Normal Sign of Aging: Mild Cognitive Impairment Takes TollApril 19th, 2022
- Join now to see all
Grant Support
- Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down SyndromeUNIVERSITY OF SOUTHERN CALIFORNIA2021–2026
- Clinical trials to prevent Alzheimer's Disease in Down SyndromeUNIVERSITY OF SOUTHERN CALIFORNIA2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
